The Telehealth in Motor Neuron Disease (TiM) digital platform, TiM on MyPathway has been awarded the BBH Award for Healthcare Software – Patient Centred.

TiM on MyPathway is a result of the partnership between ADI Health, the University of Sheffield’s Institute for Translational Research (SITraN), and Sheffield Teaching Hospital NHS Foundation Trust, funded by MND Scotland.

The need for remote monitoring and the delivery of highly specialised care, away from a hospital setting, became vital to protect vulnerable Motor Neuron Disease (MND) patients when COVID-19 hit. TiM on MyPathway allows patients and carers to connect with their healthcare provider seamlessly and securely, without the need for a physical visit. Clinicians can remotely monitor their patient and their carer and are alerted to any changes in their condition.

“It is a privilege to be working with the MND team, their patients and carers to deploy our digital “MyPathway” platform to provide improved remote support, monitoring and intervention during the pandemic and beyond. We are very pleased to see everyone’s efforts and achievements being recognised by this award”.

John Eaglesham, Chief Executive of ADI Health.

 “We’re delighted to win this award. It reflects the hard work our MND team, ADI and our patients and carers have put in to develop TiM on MyPathway. We think it can make a big difference to the care and support we give people.”

Dr Esther Hobson, Consultant Neurologist, Sheffield Teaching Hospitals NHS Foundation Trust.

“TiM on My Pathway has enhanced the care we can offer our patients and we now plan to build on the success with a major new programme of work, in collaboration with NIHR and ADI, to roll out TiM on My Pathway around the country.”

Professor Chris McDermott, Professor of Translational Neurology, Sheffield Institute for Translational Neuroscience (SITraN) & NIHR Devices for Dignity Neurological Conditions Lead

“MND Scotland congratulates the team at the University of Sheffield for this recognition for the Telehealth App. We are delighted to continue our funding of the project in partnership with the university. On the basis of progress reports to date, we look forward to future consideration of roll out of the technology to the benefit of patients affected by MND.”

Professor Scott Bryson, MND Scotland Trustee and Vice Chair of the Research Committee

This award recognises that MyPathway is specially designed for use by patients which helps to enhance their health and wellbeing.

The judges commented that MyPathway is, “an absolutely super idea for people who have this condition, it is a great way to support and monitor health and wellbeing.”

More information at